Cancer Screening & Prevention at Novo Clinic
Evidence-based cancer screening and prevention in the Cayman Islands, with personalised guidance from Dr Mike Smith to help you understand your screening needs and detect cancer earlier.
About Cancer Screening & Prevention
Overview
The Cayman Islands’ first National Cancer Policy establishes a standardised, evidence-based approach to cancer screening across the Islands. The policy currently recommends population screening for bowel (colorectal), cervical and female breast cancer, with specific age ranges, screening methods and intervals for each.
At NovoClinic, Dr Mike Smith, Consultant Gynaecologist & Gynaecological Oncologist, helps patients understand these recommendations and determine the screening pathway that is appropriate for their individual circumstances. This may include considering personal and family history, discussing cancer risk and arranging appropriate screening or follow-up where further investigation is required.
Dr Smith was acknowledged by the Cayman Islands Government for his contribution to the development of the National Cancer Policy, bringing specialist experience in gynaecology and gynaecological oncology to this important national initiative.
Service Description
Cancer screening plays an important role in preventing cancer and detecting disease at an earlier stage, when treatment can be more effective. The Cayman Islands’ first National Cancer Policy, published on 11 August 2026, establishes a standardised, evidence-based approach to population screening for bowel (colorectal), cervical and female breast cancer.
At NovoClinic, Dr Mike Smith, Consultant Gynaecologist & Gynaecological Oncologist, helps patients understand the screening recommendations that apply to them, assess relevant personal and family history, and access appropriate screening and follow-up care. Dr Smith was acknowledged by the Cayman Islands Government for his contribution to the development of the National Cancer Policy.
Focus of our Treatment
Prevention, Screening & Early Detection
Cancer screening is an important part of preventive healthcare, but screening is more than simply having a test. It involves identifying people who are eligible for screening, using the appropriate evidence-based method, interpreting results and ensuring appropriate follow-up where further investigation is required.
The Cayman Islands National Cancer Policy establishes population screening programmes for three cancers:
- Bowel (colorectal) cancer
- Cervical cancer
- Female breast cancer
These programmes are designed for people who are generally healthy and asymptomatic. If you have symptoms or there is a clinical concern about cancer, you should be assessed by a healthcare professional rather than waiting for your next routine screening appointment.
NovoClinic provides a patient-centred approach to cancer screening, helping patients understand the recommendations, consider individual risk factors and navigate the appropriate pathway.
Key Information about Cancer Screening & Prevention in Cayman
Three National Screening Programmes
The Cayman Islands National Cancer Policy currently establishes population screening programmes for bowel (colorectal), cervical and female breast cancer.
Bowel Screening
FIT every two years or colonoscopy every 10 years.
Cervical Screening
HPV testing every five years, with cytology triage where indicated.
Female Breast Screening
Mammography every two years, with additional imaging where recommended following radiological assessment.
Treatments Offered
Bowel (Colorectal) Cancer Screening
Cervical Cancer Screening
Female Breast Cancer Screening
Cancer Risk & Family History Assessment
Clinical Pathways for Cancer Screening & Prevention in Cayman
Bowel Cancer Screening
The bowel cancer screening pathway is designed to identify colorectal cancer and potentially pre-cancerous disease earlier. At-home FIT testing should be offered where possible. Patients with a positive FIT result should have timely access to colonoscopy, while colonoscopy may also be recommended when clinically necessary based on persistent symptoms.
Cervical Cancer Screening
HPV testing is the primary screening method within the national cervical cancer screening programme. Where indicated, liquid-based cytology is used as a triage test. Catch-up HPV vaccination should be offered at the first screening appointment where required. Self-sampling may also be appropriate in certain circumstances to improve access to screening.
Female Breast Cancer Screening
Mammography is the national population screening method for women aged 40–74. Radiological assessment may identify the need for additional imaging, including MRI or ultrasound, where breast density or another clinical consideration requires further assessment. Thermography is not recommended as a substitute for validated breast screening.
Individual Cancer Risk Assessment
Population screening recommendations do not apply equally to every individual. A significant family history may indicate an increased risk that requires a different clinical pathway. In particular, the National Cancer Policy identifies family-history patterns that may warrant investigation for hereditary breast and ovarian cancer risk, including consideration of BRCA1 and BRCA2.
Important Considerations
Screening vs Symptoms
Population cancer screening is intended for people who are generally healthy and asymptomatic. If you have symptoms or a clinician considers investigation clinically necessary, you should not wait until your next routine screening interval. The National Cancer Policy states that clinically necessary investigation should not be delayed because of routine screening intervals.
Screening Methods
The National Cancer Policy supports validated, evidence-based screening methods. Self-examination, routine practitioner-led physical examination and thermography are not supported as population-level cancer screening methodologies and should not be used in place of validated screening tests.
Individual Circumstances
National screening recommendations are designed for defined population groups. Your age, symptoms, previous results, personal history and family history may affect the appropriate clinical pathway. Your doctor can help determine which approach is appropriate for you.
Patient Journey
Understanding Your Cancer Screening Needs
1. Consultation
Your consultation begins with a discussion of your health, age, personal history and relevant family history. You can also raise any concerns or questions about cancer screening.
2. Determine the Appropriate Pathway
Your doctor will help determine which national screening recommendations apply to you and whether individual risk factors mean that a different assessment or referral may be appropriate.
3. Complete the Appropriate Screening
Screening is performed using the recommended method for the relevant cancer type. Depending on the pathway, this may include FIT, HPV testing or mammography.
4. Review Your Results
Screening results are reviewed and explained to you. An abnormal screening result does not necessarily mean that you have cancer, but it may mean that further investigation is required.
5. Further Investigation or Referral
Where clinically indicated, additional diagnostic testing or specialist referral can be arranged. The National Cancer Policy establishes clinical guidance for suspected cancer, breast cancer and colorectal cancer to support timely investigation and coordinated care.
6. Ongoing Care
Where further treatment or specialist management is required, your care can continue through the appropriate clinical pathway.
Clinical Expertise
Dr Mike Smith & the Cayman Islands National Cancer Policy
Dr Mike Smith, Consultant Gynaecologist & Gynaecological Oncologist at NovoClinic, was acknowledged by the Cayman Islands Government for his contribution to the development of the Cayman Islands’ first National Cancer Policy.
Published on 11 August 2026, the policy establishes national screening protocols, quality standards and clinical guidelines designed to create a more consistent, evidence-based approach to cancer prevention, early detection and care across the Cayman Islands.
Dr Smith’s specialist experience in gynaecology and gynaecological oncology is particularly relevant to the cervical cancer screening and women’s cancer risk pathways established within the policy.
The policy adopts recognised NICE quality standards and clinical guidelines as part of its framework for suspected cancer, breast cancer and colorectal cancer care.
Meet our
Cancer Screening & Prevention Providers
Dr. Mike Smith
Consultant Gynaecologist & Gynaecological Oncologist, Certified Menopause Practitioner by the International Menopause Society
Our Patients are our why.
We take a holistic approach to patient care. Integrating traditional, medical treatments with complementary therapies.
Frequently Asked Questions
What cancer screening is recommended in the Cayman Islands?
The Cayman Islands National Cancer Policy currently establishes population screening programmes for bowel (colorectal), cervical and female breast cancer. Each programme has its own recommended age range, screening method and frequency.
At what age should I start bowel cancer screening?
The national policy recommends bowel cancer screening for adults aged 45–74. The recommended options are a FIT every two years or colonoscopy every 10 years.
How often should I have a FIT test?
If you choose FIT as your bowel cancer screening method, the national recommendation is to complete the test every two years between ages 45 and 74.
When should women have cervical cancer screening?
Cervical cancer screening is recommended for women aged 24.5–64, using HPV testing every five years with cytology triage where indicated. Catch-up HPV vaccination should be offered at the first screening appointment where required.
When should women start having mammograms?
The National Cancer Policy recommends mammography every two years for women aged 40–74. Additional imaging may be recommended following radiological assessment, including where breast density requires further evaluation.
What if I have a family history of breast cancer?
Tell your doctor about your family history. The national policy recommends breast cancer family-history assessments at age 30 and again at 39, or at the mammography appointment at 40 if these assessments have not previously been completed. Certain family-history patterns may indicate the need for further investigation or hereditary cancer risk assessment.
Does an abnormal screening result mean I have cancer?
No. An abnormal screening result does not necessarily mean that you have cancer. It means that further assessment or diagnostic investigation may be required. Your doctor can explain the result and arrange the appropriate next step.
Can I have cancer screening if I have symptoms?
If you have symptoms, you should speak with a healthcare professional rather than waiting for routine screening. The national policy states that where a clinician considers investigation clinically necessary, it should not be delayed until the next routine screening interval.
Does the National Cancer Policy apply to private clinics?
Yes. The policy establishes a national framework for cancer screening and care across the Cayman Islands and includes both public and private healthcare providers within its implementation.
Does the policy cover every type of cancer?
Not currently. The population screening programmes established by the policy focus on bowel (colorectal), cervical and female breast cancer. Other cancers may be considered for future population screening as evidence and clinical practice evolve.
Can I be screened outside the recommended age range?
Population screening recommendations apply to defined age groups, but individual circumstances can require a different approach. Your age, symptoms, previous results, personal history and family history may affect the appropriate clinical pathway. Discuss your individual circumstances with your doctor.
What happens if further investigation is needed?
If a screening result or clinical assessment indicates that further investigation is required, your doctor can explain the next steps and arrange appropriate diagnostic testing or specialist referral. The National Cancer Policy includes clinical guidelines intended to support timely investigation, referral and coordinated care.
External Resources
Cayman Islands National Cancer Policy
Cayman Islands Government Cancer Policy Announcement
World Health Organization Cancer Screening Guidelines
Book Your Cancer Screening Appointment
Book Your Sub-Specialist Physician Consultation
Get expert care tailored to your unique needs. Our network of sub-specialist physicians is here to provide you with personalized, in-depth consultations for a wide range of medical conditions. Whether you’re seeking a second opinion or specialized treatment, booking an appointment has never been easier.
- Select Your Sub-Specialist
- Schedule Your Appointment
- Get the Care You Deserve
Ready to improve your health?
Book Your Consultation Now